Infinity planning follow-on

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) said late Wednesday it is planning a follow-on underwritten by Morgan Stanley and JPMorgan. Infinity was off $0.20 to $15.16 on Wednesday. ...